DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $154,064 | -8.9% | 10,942 | -0.1% | 0.00% | – |
| Q1 2023 | $169,208 | -5.6% | 10,952 | +0.1% | 0.00% | – |
| Q4 2022 | $179,339 | +45.8% | 10,942 | -17.8% | 0.00% | – |
| Q1 2022 | $123,000 | -99.9% | 13,317 | -99.6% | 0.00% | -100.0% |
| Q3 2021 | $108,595,000 | -2.9% | 3,195,854 | +4.6% | 0.04% | -4.7% |
| Q2 2021 | $111,888,000 | -35.0% | 3,056,213 | -20.4% | 0.04% | -38.6% |
| Q1 2021 | $172,219,000 | -15.9% | 3,840,734 | +7.1% | 0.07% | -19.5% |
| Q4 2020 | $204,701,000 | +18.0% | 3,586,839 | +6.0% | 0.09% | +3.6% |
| Q3 2020 | $173,525,000 | -1.0% | 3,382,551 | -4.2% | 0.08% | -6.7% |
| Q2 2020 | $175,339,000 | +31.6% | 3,531,488 | +9.1% | 0.09% | +1.1% |
| Q1 2020 | $133,283,000 | -9.7% | 3,237,383 | +36.4% | 0.09% | +14.1% |
| Q4 2019 | $147,678,000 | +437.1% | 2,372,722 | +192.9% | 0.08% | +420.0% |
| Q3 2019 | $27,493,000 | +385.1% | 810,060 | +224.0% | 0.02% | +400.0% |
| Q4 2017 | $5,668,000 | +19.4% | 250,000 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $4,748,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |